Application of the Reference Method Isotope Dilution Gas Chromatography Mass Spectrometry (ID/GC/MS) to Establish Metrological Traceability for Calibration and Control of Blood Glucose Test Systems
Overview
Affiliations
Self-monitoring of blood glucose (BG) by means of handheld BG systems is a cornerstone in diabetes therapy. The aim of this article is to describe a procedure with proven traceability for calibration and evaluation of BG systems to guarantee reliable BG measurements. Isotope dilution gas chromatography mass spectrometry (ID/GC/MS) is a method that fulfills all requirements to be used in a higher-order reference measurement procedure. However, this method is not applicable for routine measurements because of the time-consuming sample preparation. A hexokinase method with perchloric acid (PCA) sample pretreatment is used in a measurement procedure for such purposes. This method is directly linked to the ID/GC/MS method by calibration with a glucose solution that has an ID/GC/MS-determined target value. BG systems are calibrated with whole blood samples. The glucose levels in such samples are analyzed by this ID/GC/MS-linked hexokinase method to establish traceability to higher-order reference material. For method comparison, the glucose concentrations in 577 whole blood samples were measured using the PCA-hexokinase method and the ID/GC/MS method; this resulted in a mean deviation of 0.1%. The mean deviation between BG levels measured in >500 valid whole blood samples with BG systems and the ID/GC/MS was 1.1%. BG systems allow a reliable glucose measurement if a true reference measurement procedure, with a noninterrupted traceability chain using ID/GC/MS linked hexokinase method for calibration of BG systems, is implemented. Systems should be calibrated by means of a traceable and defined measurement procedure to avoid bias.
Mader J, Baumstark A, Tuting J, Sokol G, Schuebel R, Tong Y Diabetes Ther. 2024; 15(12):2525-2535.
PMID: 39466547 PMC: 11561228. DOI: 10.1007/s13300-024-01665-9.
Maslyuk V, Zavilopulo A, Svatiuk N, Bandurin Y Cell Biochem Biophys. 2023; 82(1):203-211.
PMID: 37966623 DOI: 10.1007/s12013-023-01195-4.
Wang Y, Plebani M, Sciacovelli L, Zhang S, Wang Q, Zhou R J Clin Lab Anal. 2020; 34(8):e23327.
PMID: 32342567 PMC: 7439342. DOI: 10.1002/jcla.23327.
Fokkert M, van Dijk P, Edens M, Abbes S, de Jong D, Slingerland R BMJ Open Diabetes Res Care. 2017; 5(1):e000320.
PMID: 28243449 PMC: 5316912. DOI: 10.1136/bmjdrc-2016-000320.
Freckmann G, Schmid C, Baumstark A, Rutschmann M, Haug C, Heinemann L J Diabetes Sci Technol. 2015; 9(4):885-94.
PMID: 25872965 PMC: 4525642. DOI: 10.1177/1932296815580160.